Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Scientists at Bristol-Myers Squibb prepare novel agents for HIV infection

March 7, 2013

Health Canada declines to approve Theratechnologies' NDS for Egrifta

March 5, 2013

Biosantech initiates phase I/II trial of synthetic AIDS vaccine Tat Oyi

March 5, 2013

ViiV Healthcare grants voluntary license to increase access to HIV medicine for children

March 1, 2013

FDA grants priority review to dolutegravir NDA

Feb. 18, 2013

Tricyclic pim kinase inhibitors reported by the Spanish CNIO

Feb. 4, 2013

FAK inhibitors described at Merck & Co.

Feb. 4, 2013

New anti-properdin antibodies developed at the University of Pennsylvania

Feb. 1, 2013

Shionogi & Co. presents novel agents for HIV

Jan. 30, 2013

New agents for HIV infection presented by Gilead Sciences

Jan. 28, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...